Latest News

New drugs offer hope for migraine prevention

Two new studies may offer hope for people with migraines. Both studies involve drugs that are aimed at preventing migraine attacks from occurring, rather than stopping the attacks once they have started. These studies are the first to test monoclonal antibodies for the prevention of migraine, and both are directed against a relatively new target in migraine prevention, the calcitonin gene-related peptide, or CGRP. CGRP has been thought to be important in migraine, but never have drugs been developed to specifically target the protein.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Firelight talk of the Kalahari Bushmen: Did tales told over fires aid our social and cultural evolution?

  • Statin use during hospitalization for hemorrhagic stroke associated with improved survival

  • Few kids receive psychotherapy along with medication for ADHD, study finds

  • Cheater, cheater: Study shows what happens when employees feel excluded at work

  • We drink more alcohol on gym days

  • New measure provides more data on oxygen levels during sedation

  • Presence or absence of early language delay alters anatomy of the brain in autism

  • Artificial intelligence that imitates children?s learning

  • Fruit and vegetable consumption could be as good for your mental as your physical health

  • Lack of sleep increases risk of failure in school

  •